Literature DB >> 15947689

Bladder reconstitution with bone marrow derived stem cells seeded on small intestinal submucosa improves morphological and molecular composition.

Steve Y Chung1, Nikola P Krivorov, Veronica Rausei, Lisa Thomas, Malka Frantzen, Douglas Landsittel, Young M Kang, Chris H Chon, Christopher S Ng, Gerhard J Fuchs.   

Abstract

PURPOSE: Tissue engineering has been used for bladder augmentations with small intestinal submucosa (SIS). Although favorable short-term outcomes have been reported, long-term followup has been poor. We investigate whether tissue engineering with stem cells improves the morphological and genetic composition.
MATERIALS AND METHODS: A total of 33 Lewis rats (Harlan Laboratories, Indianapolis, Indiana) were used to investigate bladder augmentations with 4-layer SIS in certain groups, including the control group (sham operation), partial cystectomy with oversewn defect group (OG), augmentation with unseeded SIS group (USG) and augmentation with stem cell seeded SIS group (SSG). Bladders from 4 rats per group were harvested 1 and 3 months after surgery. Morphological analyses were performed using Masson's trichrome and immunohistochemical staining with cytokeratin AE1/AE3, smooth muscle alpha-actin and S100. Gene expression was evaluated using quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for collagen I (CI), collagen III (CIII), cytokeratins 8 and 19, and smooth muscle myosin heavy chain (MHC).
RESULTS: At 1 month trichrome staining revealed collagen admixed with indiscrete cells and morphology similar to that in controls in USG and SSG, respectively. Discrete smooth muscles fascicles and S100 staining were found in all groups except USG. Organized urothelium with increased basal cell layer staining was present in controls and SSG only. At 3 months increased collagen formation was present in OG and USG. Immunostaining showed hyperplasia of the urothelium with increased staining of the basal cell layer, discrete muscle fascicles and positive nerve staining in all groups. Using quantitative RT-PCR expression levels in SSG were more improved than in USG, especially for CI, CIII and MHC. This was further evident at 3 months when CI and CIII were over expressed in OG and USG but not in the control group or SSG. Furthermore, RT-PCR showed that cytokeratins 8 and 19, and MHC had greater expression levels in SSG than in USG.
CONCLUSIONS: Bladder reconstitution occurs more rapidly using stem cell seeded SIS. Although in USG and SSG all 3 cellular constituents appear to develop by 3 months, only SSG had gene expression levels similar to those in controls. The results suggest an explanation for the fibrosis noted in unseeded SIS bladder augmentations and the possible solution using stem cells.

Entities:  

Mesh:

Year:  2005        PMID: 15947689     DOI: 10.1097/01.ju.0000161592.00434.c1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  34 in total

1.  Bone marrow stem cells for urologic tissue engineering.

Authors:  Dave Shukla; Geoffrey N Box; Robert A Edwards; Darren R Tyson
Journal:  World J Urol       Date:  2008-07-25       Impact factor: 4.226

Review 2.  Bladder tissue engineering through nanotechnology.

Authors:  Daniel A Harrington; Arun K Sharma; Bradley A Erickson; Earl Y Cheng
Journal:  World J Urol       Date:  2008-06-07       Impact factor: 4.226

Review 3.  Will regenerative medicine replace transplantation?

Authors:  Giuseppe Orlando; Shay Soker; Robert J Stratta; Anthony Atala
Journal:  Cold Spring Harb Perspect Med       Date:  2013-08-01       Impact factor: 6.915

Review 4.  [Stem cell therapy and tissue engineering in regenerative urology].

Authors:  M Vaegler; B Amend; W Aicher; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2013-12       Impact factor: 0.639

5.  Tissue engineering in urology.

Authors:  Derek J Matoka; Earl Y Cheng
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

6.  Bladder reconstruction: The past, present and future.

Authors:  Omar M S El-Taji; Altaf Q Khattak; Syed A Hussain
Journal:  Oncol Lett       Date:  2015-04-28       Impact factor: 2.967

Review 7.  Stem Cells in Functional Bladder Engineering.

Authors:  Jakub Smolar; Souzan Salemi; Maya Horst; Tullio Sulser; Daniel Eberli
Journal:  Transfus Med Hemother       Date:  2016-08-31       Impact factor: 3.747

8.  The use of mesenchymal stem cells in bladder augmentation.

Authors:  Mila Torii Corrêa Leite; Luiz G Freitas-Filho; Andréia Silva Oliveira; Patrícia Semedo-Kuriki; Marcus Laks; Victor Eduardo Arrua Arias; Pedro S Peixoto
Journal:  Pediatr Surg Int       Date:  2014-04       Impact factor: 1.827

9.  Minimal modulation of the host immune response to SIS matrix implants by mesenchymal stem cells from the amniotic fluid.

Authors:  F Lesage; S Pranpanus; F M Bosisio; M Jacobs; S Ospitalieri; J Toelen; J Deprest
Journal:  Hernia       Date:  2017-07-27       Impact factor: 4.739

Review 10.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.